CORCEPT THERAPEUTICS INC (CORT) Stock Cash Flow
NASDAQ:CORT - Nasdaq - US2183521028 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 141.80M | 106.14M | 101.40M | 112.50M | 106.00M | |||
| Depreciation Amortization | 1.06M | 1.04M | 800.00K | 1.10M | 500.00K | |||
| Income Taxes - Deferred | -40.03M | -29.49M | -33.90M | 4.30M | 14.10M | |||
| Change In Working Capital | -4.33M | 8.22M | 6.00M | -100.00K | -5.40M | |||
| Taxes Paid | N/A | 47.60M | 39.70M | 9.10M | 10.90M | |||
| Other non cash items | 46.10M | 41.13M | 46.00M | 50.00M | 36.70M | |||
| OPERATING CASH FLOW | 144.61M | 127.04M | 120.30M | 167.90M | 152.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -139.00K | -400.00K | -500.00K | -1.20M | |||
| Other Investing Activity | -94.05M | 91.05M | -113.90M | 136.60M | -118.00M | |||
| INVESTING CASH FLOW | -96.14M | 90.91M | -114.30M | 136.10M | -119.30M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | -10.61M | -139.62M | 4.40M | -279.80M | 13.30M | |||
| Other Financing Activity | -12.39M | -9.11M | -21.70M | -22.80M | -1.10M | |||
| FINANCING CASH FLOW | -23.01M | -148.72M | -17.30M | -302.60M | 12.20M | |||
| CHANGE IN CASH | 25.46M | 69.22M | -11.30M | 1.40M | 44.90M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 144.61M | 127.04M | 120.30M | 167.90M | 152.00M | |||
| Capital Expenditure | N/A | -139.00K | -400.00K | -500.00K | -1.20M | |||
| FREE CASH FLOW | 142.52M | 126.90M | 119.90M | 167.40M | 150.80M | |||
All data in USD